{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:56:31Z","timestamp":1790207791843,"version":"4.1.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-101424-B-I00"],"award-info":[{"award-number":["RTI2018-101424-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Conselleria d'Educaci\u00f3, Investigaci\u00f3, Cultura i Esport","doi-asserted-by":"publisher","award":["PROMETEO\/2020\/032"],"award-info":[{"award-number":["PROMETEO\/2020\/032"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004834","name":"Universitat Jaume I","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Motivational symptoms such as anergia, fatigue, and reduced exertion of effort are seen in depressed people. To model this, nucleus accumbens (Nacb) dopamine (DA) depletions are used to induce a low-effort bias in rodents tested on effort-based decision-making. We evaluated the effect of the catecholamine uptake blocker bupropion on its own, and after administration of tetrabenazine (TBZ), which blocks vesicular storage, depletes DA, and induces depressive symptoms in humans. Male CD1 mice were tested on a 3-choice-T-maze task that assessed preference between a reinforcer involving voluntary physical activity (running wheel, RW) vs. sedentary activities (sweet food pellet intake or a neutral non-social odor). Mice also were tested on the forced swim test (FST), two anxiety-related measures (dark\u2013light box (DL), and elevated plus maze (EPM)). Expression of phosphorylated DARPP-32 (Thr34 and Thr75) was evaluated by immunohistochemistry as a marker of DA-related signal transduction. Bupropion increased selection of RW activity on the T-maze. TBZ reduced time running, but increased time-consuming sucrose, indicating an induction of a low-effort bias, but not an effect on primary sucrose motivation. In the FST, bupropion reduced immobility, increasing swimming and climbing, and TBZ produced the opposite effects. Bupropion reversed the effects of TBZ on the T-maze and the FST, and also on pDARPP32-Thr34 expression in Nacb core. None of these manipulations affected anxiety-related parameters. Thus, bupropion improved active behaviors, which were negatively motivated in the FST, and active behaviors that were positively motivated in the T-maze task, which has implications for using catecholamine uptake inhibitors for treating anergia and fatigue-like symptoms.<\/jats:p>","DOI":"10.1007\/s00213-021-05950-4","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T03:28:52Z","timestamp":1631158132000},"page":"3357-3373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Energizing effects of bupropion on effortful behaviors in mice under positive and negative test conditions: modulation of DARPP-32 phosphorylation patterns"],"prefix":"10.1007","volume":"238","author":[{"given":"Carla","family":"Carratal\u00e1-Ros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gulo","family":"Olivares-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mart\u00ednez-Verd\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Arias-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"5950_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1177\/0269881113494104","volume":"27","author":"SV Argyropoulos","year":"2013","unstructured":"Argyropoulos SV, Nutt DJ (2013) Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression? J Psychopharmacol 27:869\u2013877. https:\/\/doi.org\/10.1177\/0269881113494104","journal-title":"J Psychopharmacol"},{"key":"5950_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2021.06.014","volume":"128","author":"A Armario","year":"2021","unstructured":"Armario A (2021) The forced swim test: historical, conceptual and methodological considerations and its relationship with individual behavioral traits. Neurosci Biobehav Rev 128:74\u201386. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.06.014","journal-title":"Neurosci Biobehav Rev"},{"key":"5950_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fphar.2013.00137","volume":"4","author":"A Armario","year":"2013","unstructured":"Armario A, Nadal R (2013) Individual differences and the characterization of animal models of psychopathology: a strong challenge and a good opportunity. Front Pharmacol 4:137. https:\/\/doi.org\/10.3389\/fphar.2013.00137","journal-title":"Front Pharmacol"},{"key":"5950_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-2999(88)90068-4","volume":"158","author":"A Armario","year":"1988","unstructured":"Armario A, Gavald\u00e0 A, Mart\u00ed O (1988) Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Eur J Pharmacol 158:207\u2013212. https:\/\/doi.org\/10.1016\/0014-2999(88)90068-4","journal-title":"Eur J Pharmacol"},{"key":"5950_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/7854_2015_376","volume":"27","author":"DM Barch","year":"2016","unstructured":"Barch DM, Pagliaccio D, Luking K (2016) Mechanisms underlying motivational deficits in psychopathology: similarities and differences in depression and schizophrenia. Curr Top Behav Neurosci 27:411\u2013449. https:\/\/doi.org\/10.1007\/7854_2015_376","journal-title":"Curr Top Behav Neurosci"},{"key":"5950_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nn.2153","volume":"11","author":"HS Bateup","year":"2009","unstructured":"Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Heintz N, Greengard P (2009) Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11:932\u2013939. https:\/\/doi.org\/10.1038\/nn.2153","journal-title":"Nat Neurosci"},{"key":"5950_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1901\/jeab.1969.12-861","volume":"12","author":"WM Baum","year":"1969","unstructured":"Baum WM, Rachlin HC (1969) Choice as time allocation. J Exp Anal Behav 12:861\u2013874. https:\/\/doi.org\/10.1901\/jeab.1969.12-861","journal-title":"J Exp Anal Behav"},{"key":"5950_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.beproc.2005.08.003","volume":"71","author":"TW Belke","year":"2006","unstructured":"Belke TW (2006) Responding for sucrose and wheel-running reinforcement: effect of prerunning. Behav Process 71:1\u20137. https:\/\/doi.org\/10.1016\/j.beproc.2005.08.003","journal-title":"Behav Process"},{"key":"5950_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.beproc.2013.11.010","volume":"103","author":"TW Belke","year":"2014","unstructured":"Belke TW, Pierce WD (2014) Effect of sucrose availability and pre-running on the intrinsic value of wheel running as an operant and a reinforcing consequence. Behav Process 103:35\u201342. https:\/\/doi.org\/10.1016\/j.beproc.2013.11.010","journal-title":"Behav Process"},{"key":"5950_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0091-3057(83)90247-2","volume":"18","author":"LK Blumstein","year":"1983","unstructured":"Blumstein LK, Crawley JN (1983) Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 18:37\u201340. https:\/\/doi.org\/10.1016\/0091-3057(83)90247-2","journal-title":"Pharmacol Biochem Behav"},{"key":"5950_CR11","doi-asserted-by":"publisher","unstructured":"Bonito-Oliva A, Feyder M, Fisone G (2011) Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP\/DARPP-32 signaling. Front Neuroanat 5. https:\/\/doi.org\/10.3389\/fnana.2011.00038","DOI":"10.3389\/fnana.2011.00038"},{"key":"5950_CR12","doi-asserted-by":"publisher","unstructured":"Borderies N, Bornert P, Gilardeau S, Bouret S (2020) Pharmacological evidence for the implication of noradrenaline in effort. PLoS Biol 18. https:\/\/doi.org\/10.1371\/journal.pbio.3000793","DOI":"10.1371\/journal.pbio.3000793"},{"key":"5950_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbr.2005.06.015","volume":"164","author":"M Bourin","year":"2005","unstructured":"Bourin M, Chenu F, Ripoll N, David DJP (2005) A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav Brain Res 164:266\u2013269. https:\/\/doi.org\/10.1016\/j.bbr.2005.06.015","journal-title":"Behav Brain Res"},{"key":"5950_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01245227","volume":"91","author":"AS Brown","year":"1993","unstructured":"Brown AS, Gershon S (1993) Dopamine and depression. J Neural Transm 91:75\u2013109. https:\/\/doi.org\/10.1007\/BF01245227","journal-title":"J Neural Transm"},{"key":"5950_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/syn.10242","volume":"50","author":"AW Bruijnzeel","year":"2003","unstructured":"Bruijnzeel AW, Arkou AM (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50:20\u201328. https:\/\/doi.org\/10.1002\/syn.10242","journal-title":"Synapse"},{"key":"5950_CR16","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/sj.npp.1300966","volume":"31","author":"B Cagniard","year":"2006","unstructured":"Cagniard B, Balsam PD, Brunner D, Zhuang X (2006) Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology 31:1362\u20131370. https:\/\/doi.org\/10.1038\/sj.npp.1300966","journal-title":"Neuropsychopharmacology"},{"key":"5950_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-0327(99)00068-3","volume":"57","author":"MP Caligiuri","year":"2000","unstructured":"Caligiuri MP, Ellwanger J (2000) Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57:83\u201393. https:\/\/doi.org\/10.1016\/S0165-0327(99)00068-3","journal-title":"J Affect Disord"},{"key":"5950_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.pnpbp.2004.06.005","volume":"28","author":"MC Carrasco","year":"2004","unstructured":"Carrasco MC, Vicens P, Vidal J, Redolat R (2004) Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice. Prog Neuro-Psychopharmacol Biol Psychiatry 28:1135\u20131141. https:\/\/doi.org\/10.1016\/j.pnpbp.2004.06.005","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5950_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.beproc.2013.05.002","volume":"98","author":"MC Carrasco","year":"2013","unstructured":"Carrasco MC, Vidal J, Redolat R (2013) Bupropion induced changes in exploratory and anxiety-like behaviour in NMRI male mice depends on the age. Behav Process 98:117\u2013124. https:\/\/doi.org\/10.1016\/j.beproc.2013.05.002","journal-title":"Behav Process"},{"key":"5950_CR20","doi-asserted-by":"publisher","unstructured":"Carratal\u00e1-Ros C, L\u00f3pez-Cruz L, SanMiguel N, Ib\u00e1\u00f1ez-Mar\u00edn P, Mart\u00ednez-Verd\u00fa A, Salamone J D et al (2020) Preference for exercise vs. more sedentary reinforcers: validation of an animal model of tetrabenazine-induced anergia. Front Behav Neurosc 13. https:\/\/doi.org\/10.3389\/fnbeh.2019.00289","DOI":"10.3389\/fnbeh.2019.00289"},{"key":"5950_CR21","doi-asserted-by":"publisher","unstructured":"Carratal\u00e1-Ros C, L\u00f3pez-Cruz L, Mart\u00ednez-Verd\u00fa A, Olivares-Garc\u00eda R, Salamone JD, Correa M (2021) Impact of fluoxetine on behavioral invigoration of appetitive and aversively motivated responses: interaction with dopamine depletion. Behav Neurosci Front 15:700182. https:\/\/doi.org\/10.3389\/fnbeh.2021.700182","DOI":"10.3389\/fnbeh.2021.700182"},{"key":"5950_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.clinthera.2012.06.010","volume":"34","author":"JJ Chen","year":"2012","unstructured":"Chen JJ, Ondo WG, Dashtipour K, Swope DM (2012) Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 34:1487\u20131504. https:\/\/doi.org\/10.1016\/j.clinthera.2012.06.010","journal-title":"Clin Ther"},{"key":"5950_CR23","doi-asserted-by":"publisher","unstructured":"Chong TTJ, Bonnelle V, Husain M (2016) Quantifying motivation with effort-based decision-making paradigms in health and disease. In: Progress in Brain Research (Elsevier B.V.), p 71\u2013100. https:\/\/doi.org\/10.1016\/bs.pbr.2016.05.002","DOI":"10.1016\/bs.pbr.2016.05.002"},{"key":"5950_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0269881113514878","volume":"28","author":"JA Cooper","year":"2014","unstructured":"Cooper JA, Tucker VL, Papakostas GI (2014) Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union. J Psychopharmacol 28:118\u2013124. https:\/\/doi.org\/10.1177\/0269881113514878","journal-title":"J Psychopharmacol"},{"key":"5950_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00213-015-4127-3","volume":"233","author":"M Correa","year":"2016","unstructured":"Correa M, Pardo M, Bayarri P, L\u00f3pez-Cruz L, San Miguel N, Valverde O et al (2016) Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A2AKO mice. Psychopharmacology 233:393\u2013404. https:\/\/doi.org\/10.1007\/s00213-015-4127-3","journal-title":"Psychopharmacology"},{"key":"5950_CR26","doi-asserted-by":"publisher","unstructured":"Correa M, SanMiguel N, L\u00f3pez-Cruz L, Carratal\u00e1-Ros C, Olivares-Garc\u00eda R, Salamone JD (2018) Caffeine modulates food intake depending on the context that gives access to food: comparison with dopamine depletion. Front Psychiatry 9. https:\/\/doi.org\/10.3389\/fpsyt.2018.00411","DOI":"10.3389\/fpsyt.2018.00411"},{"key":"5950_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000556","author":"M Correa","year":"2020","unstructured":"Correa M, Pardo M, Carratal\u00e1-Ros C, Mart\u00ednez-Verd\u00fa A, Salamone JD (2020). Preference for vigorous exercise versus sedentary sucrose drinking: an animal model of anergia induced by dopamine receptor antagonism. https:\/\/doi.org\/10.1097\/FBP.0000000000000556","journal-title":"Preference for vigorous exercise versus sedentary sucrose drinking: an animal model of anergia induced by dopamine receptor antagonism"},{"key":"5950_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0091-3057(02)00853-5","volume":"73","author":"KP Cosgrove","year":"2002","unstructured":"Cosgrove KP, Hunter RG, Carroll ME (2002) Wheel-running attenuates intravenous cocaine self-administration in rats: Sex differences. Pharmacol Biochem Behav 73:663\u2013671. https:\/\/doi.org\/10.1016\/S0091-3057(02)00853-5","journal-title":"Pharmacol Biochem Behav"},{"key":"5950_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pnpbp.2013.05.002","volume":"45","author":"APR Costa","year":"2013","unstructured":"Costa APR, Vieira C, Bohner LOL, Silva CF, da Silva Santos EC, De Lima TCM et al (2013) A proposal for refining the forced swim test in Swiss mice. Prog Neuro-Psychopharmacol Biol Psychiatry 45:150\u2013155. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.05.002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5950_CR30","doi-asserted-by":"publisher","unstructured":"Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11. https:\/\/doi.org\/10.1186\/1741-7015-11-126","DOI":"10.1186\/1741-7015-11-126"},{"key":"5950_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1461145704004729","volume":"8","author":"K Demyttenaere","year":"2005","unstructured":"Demyttenaere K, De Fruyt J, Stahl SM (2005) The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol 8:93\u2013105. https:\/\/doi.org\/10.1017\/S1461145704004729","journal-title":"Int J Neuropsychopharmacol"},{"key":"5950_CR32","doi-asserted-by":"publisher","first-page":"e0184829","DOI":"10.1371\/journal.pone.0184829","volume":"12","author":"E DeVallance","year":"2017","unstructured":"DeVallance E, Riggs D, Jackson B, Parkulo T, Zaslau S, Chantler PD, Olfert IM, Bryner RW (2017) Effect of chronic stress on running wheel activity in mice. PLoS One 12:e0184829. https:\/\/doi.org\/10.1371\/journal.pone.0184829","journal-title":"PLoS One"},{"key":"5950_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","volume":"12","author":"LP Dwoskin","year":"2006","unstructured":"Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT (2006) Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 12:178\u2013207. https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00178.x","journal-title":"CNS Drug Rev"},{"key":"5950_CR34","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/da.22199","volume":"31","author":"M Fava","year":"2014","unstructured":"Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P et al (2014) Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety 31:250\u2013257. https:\/\/doi.org\/10.1002\/da.22199","journal-title":"Depress Anxiety"},{"key":"5950_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00004714-198602000-00006","volume":"6","author":"J Feighner","year":"1986","unstructured":"Feighner J, Hendrickson G, Miller L, Stern W (1986) Double-Blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder. J Clin Psychopharmacol 6:27\u201332. https:\/\/doi.org\/10.1097\/00004714-198602000-00006","journal-title":"J Clin Psychopharmacol"},{"key":"5950_CR36","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1523\/JNEUROSCI.3191-17.2018","volume":"38","author":"SB Floresco","year":"2018","unstructured":"Floresco SB, Montes DR, Tse MMT, van Holstein M (2018) Differential contributions of nucleus accumbens subregions to cue-guided risk\/reward decision making and implementation of conditional rules. J Neurosci 38:1901\u20131914. https:\/\/doi.org\/10.1523\/JNEUROSCI.3191-17.2018","journal-title":"J Neurosci"},{"key":"5950_CR37","doi-asserted-by":"publisher","unstructured":"Frank S (2009) Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group\/TETRA-HD Investigators. BMC Neurol 9. https:\/\/doi.org\/10.1186\/1471-2377-9-62","DOI":"10.1186\/1471-2377-9-62"},{"key":"5950_CR38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1523\/JNEUROSCI.4418-08.2009","volume":"29","author":"T Fukuda","year":"2009","unstructured":"Fukuda T (2009) Network architecture of gap junction-coupled neuronal linkage in the striatum. J Neurosci 29:1235\u20131243. https:\/\/doi.org\/10.1523\/JNEUROSCI.4418-08.2009","journal-title":"J Neurosci"},{"key":"5950_CR39","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1523\/JNEUROSCI.4388-06.2007","volume":"27","author":"M Fukui","year":"2007","unstructured":"Fukui M, Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG et al (2007) Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci 27:10520\u201310529. https:\/\/doi.org\/10.1523\/JNEUROSCI.4388-06.2007","journal-title":"J Neurosci"},{"key":"5950_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0166-4328(97)00109-5","volume":"91","author":"M Gil","year":"1998","unstructured":"Gil M, Armario A (1998) Chronic immobilization stress appears to increase the role of dopamine in the control of active behaviour in the forced swimming test. Behav Brain Res 91:91\u201397. https:\/\/doi.org\/10.1016\/S0166-4328(97)00109-5","journal-title":"Behav Brain Res"},{"key":"5950_CR41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4088\/JCP.13r08560","volume":"74","author":"AJ Goss","year":"2013","unstructured":"Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CHY (2013) Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 74:1101\u20131107. https:\/\/doi.org\/10.4088\/JCP.13r08560","journal-title":"J Clin Psychiatry"},{"key":"5950_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.amjopharm.2010.08.006","volume":"8","author":"DRP Guay","year":"2010","unstructured":"Guay DRP (2010) Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriatr Pharmacother 8:331\u2013373. https:\/\/doi.org\/10.1016\/j.amjopharm.2010.08.006","journal-title":"Am J Geriatr Pharmacother"},{"key":"5950_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2119\/molmed.2012.00053","volume":"18","author":"BT Gurfein","year":"2012","unstructured":"Gurfein BT, Stamm AW, Bacchetti P, Dallman MF, Nadkarni NA, Milush JM, Touma C, Palme R, Di Borgo CP, Fromentin G, Lown-Hecht R, Konsman JP, Acree M, Premenko-Lanier M, Darcel N, Hecht FM, Nixon DF (2012) The calm mouse: an animal model of stress reduction. Mol Med 18:606\u2013617. https:\/\/doi.org\/10.2119\/molmed.2012.00053","journal-title":"Mol Med"},{"key":"5950_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.lfs.2010.12.016","volume":"88","author":"E Hayashi","year":"2011","unstructured":"Hayashi E, Shimamura M, Kuratani K, Kinoshita M, Hara H (2011) Automated experimental system capturing three behavioral components during murine forced swim test. Life Sci 88:411\u2013417. https:\/\/doi.org\/10.1016\/j.lfs.2010.12.016","journal-title":"Life Sci"},{"key":"5950_CR45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/npp.2014.285","volume":"40","author":"JG Hosking","year":"2015","unstructured":"Hosking JG, Floresco SB, Winstanley CA (2015) Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost\/benefit decision-making tasks. Neuropsychopharmacology 40:1005\u20131015. https:\/\/doi.org\/10.1038\/npp.2014.285","journal-title":"Neuropsychopharmacology"},{"key":"5950_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1139\/Y2012-045","volume":"90","author":"AL Hudson","year":"2012","unstructured":"Hudson AL, Lalies MD, Silverstone P (2012) Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Can J Physiol Pharmacol 90:803\u2013809. https:\/\/doi.org\/10.1139\/Y2012-045","journal-title":"Can J Physiol Pharmacol"},{"key":"5950_CR47","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00213-017-4587-8","volume":"234","author":"JR Hufgard","year":"2017","unstructured":"Hufgard JR, Williams MT, Skelton MR, Grubisha O, Ferreira FM, Sanger H et al (2017) Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a. Psychopharmacology 234:1803\u20131813. https:\/\/doi.org\/10.1007\/s00213-017-4587-8","journal-title":"Psychopharmacology"},{"key":"5950_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2008.12.024","volume":"451","author":"DP Jang","year":"2009","unstructured":"Jang DP, Lee SH, Park CW, Lee SY, Kim YB, Cho ZH (2009) Effects of fluoxetine on the rat brain in the forced swimming test: a [F-18]FDG micro-PET imaging study. Neurosci Lett 451:60\u201364. https:\/\/doi.org\/10.1016\/j.neulet.2008.12.024","journal-title":"Neurosci Lett"},{"key":"5950_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/10401239409148989","volume":"6","author":"A Kiev","year":"1994","unstructured":"Kiev A, Masco HL, Wenger TL, Johnston JA, Batey SR, Holloman LC (1994) The cardiovascular effects of bupropion and nortriptyline in depressed outpatients. Ann Clin Psychiatry 6:107\u2013115. https:\/\/doi.org\/10.3109\/10401239409148989","journal-title":"Ann Clin Psychiatry"},{"key":"5950_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1248\/bpb.31.246","volume":"31","author":"Y Kitamura","year":"2008","unstructured":"Kitamura Y, Fujitani Y, Kitagawa K, Miyazaki T, Sagara H, Kawasaki H et al (2008) Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA. Biol Pharm Bull 31:246\u2013249. https:\/\/doi.org\/10.1248\/bpb.31.246","journal-title":"Biol Pharm Bull"},{"key":"5950_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-010-0521-x","volume":"382","author":"Y Kitamura","year":"2010","unstructured":"Kitamura Y, Yagi T, Kitagawa K, Shinomiya K, Kawasaki H, Asanuma M et al (2010) Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. Naunyn Schmiedebergs Arch Pharmacol 382:151\u2013158. https:\/\/doi.org\/10.1007\/s00210-010-0521-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5950_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pbb.2017.12.010","volume":"174","author":"D Knowland","year":"2018","unstructured":"Knowland D, Lim BK (2018) Circuit-based frameworks of depressive behaviors: the role of reward circuitry and beyond. Pharmacol Biochem Behav 174:42\u201352. https:\/\/doi.org\/10.1016\/j.pbb.2017.12.010","journal-title":"Pharmacol Biochem Behav"},{"key":"5950_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","volume":"54","author":"SM Learned-Coughlin","year":"2003","unstructured":"Learned-Coughlin SM, Bergstr\u00f6m M, Savitcheva I, Ascher J, Schmith VD, L\u00e5ngstrom B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 54:800\u2013805. https:\/\/doi.org\/10.1016\/S0006-3223(02)01834-6","journal-title":"Biol Psychiatry"},{"key":"5950_CR54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","volume":"279","author":"Y Li","year":"2015","unstructured":"Li Y, Zhu ZR, Ou BC, Wang YQ, Tan ZB, Deng CM et al (2015) Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test. Behav Brain Res 279:100\u2013105. https:\/\/doi.org\/10.1016\/j.bbr.2014.11.016","journal-title":"Behav Brain Res"},{"key":"5950_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00177912","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180\u2013185. https:\/\/doi.org\/10.1007\/BF00177912","journal-title":"Psychopharmacology"},{"key":"5950_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbr.2016.12.020","volume":"321","author":"L L\u00f3pez-Cruz","year":"2017","unstructured":"L\u00f3pez-Cruz L, Carb\u00f3-Gas M, Pardo M, Bayarri P, Valverde O, Ledent C et al (2017) Adenosine A2Areceptor deletion affects social behaviors and anxiety in mice: involvement of anterior cingulate cortex and amygdala. Behav Brain Res 321:8\u201317. https:\/\/doi.org\/10.1016\/j.bbr.2016.12.020","journal-title":"Behav Brain Res"},{"key":"5950_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuropharm.2018.01.034","volume":"138","author":"L L\u00f3pez-Cruz","year":"2018","unstructured":"L\u00f3pez-Cruz L, San Miguel N, Carratal\u00e1-Ros C, Monferrer L, Salamone JD, Correa M (2018) Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: relation to ventral striatum DARPP32 phosphorylation patterns. Neuropharmacology 138:349\u2013359. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.034","journal-title":"Neuropharmacology"},{"key":"5950_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","volume":"8","author":"I Lucki","year":"1997","unstructured":"Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523\u2013532. https:\/\/doi.org\/10.1097\/00008877-199711000-00010","journal-title":"Behav Pharmacol"},{"key":"5950_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","volume":"12","author":"B Mai","year":"2012","unstructured":"Mai B, Sommer S, Hauber W (2012) Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn Affect Behav Neurosci 12:74\u201384. https:\/\/doi.org\/10.3758\/s13415-011-0068-4","journal-title":"Cogn Affect Behav Neurosci"},{"key":"5950_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0004867416634208","volume":"50","author":"GS Malhi","year":"2016","unstructured":"Malhi GS, Byrow Y, Bassett D, Boyce P, Hopwood M, Lyndon W et al (2016) Stimulants for depression: on the up and up? Aust N Z J Psychiatry 50:203\u2013207. https:\/\/doi.org\/10.1177\/0004867416634208","journal-title":"Aust N Z J Psychiatry"},{"key":"5950_CR61","doi-asserted-by":"publisher","unstructured":"Manzanares G, Brito-Da-Silva G, Gandra PG (2019) Voluntary wheel running: patterns and physiological effects in mice. Braz J Med Biol Res 52. https:\/\/doi.org\/10.1590\/1414-431X20187830","DOI":"10.1590\/1414-431X20187830"},{"key":"5950_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0376-8716(95)01162-5","volume":"40","author":"DE McMillan","year":"1995","unstructured":"McMillan DE, McClure GYH, Hardwick WC (1995) Effects of access to a running wheel on food, water and ethanol intake in rats bred to accept ethanol. Drug Alcohol Depend 40:1\u20137. https:\/\/doi.org\/10.1016\/0376-8716(95)01162-5","journal-title":"Drug Alcohol Depend"},{"key":"5950_CR63","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s00429-018-1749-3","volume":"223","author":"Y Miyamoto","year":"2018","unstructured":"Miyamoto Y, Katayama S, Shigematsu N, Nishi A, Fukuda T (2018) Striosome-based map of the mouse striatum that is conformable to both cortical afferent topography and uneven distributions of dopamine D1 and D2 receptor-expressing cells. Brain Struct Funct 223:4275\u20134291. https:\/\/doi.org\/10.1007\/s00429-018-1749-3","journal-title":"Brain Struct Funct"},{"key":"5950_CR64","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00429-019-01928-3","volume":"224","author":"Y Miyamoto","year":"2019","unstructured":"Miyamoto Y, Nagayoshi I, Nishi A, Fukuda T (2019) Three divisions of the mouse caudal striatum differ in the proportions of dopamine D1 and D2 receptor-expressing cells, distribution of dopaminergic axons, and composition of cholinergic and GABAergic interneurons. Brain Struct Funct 224:2703\u20132716. https:\/\/doi.org\/10.1007\/s00429-019-01928-3","journal-title":"Brain Struct Funct"},{"key":"5950_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.psyneuen.2015.08.028","volume":"62","author":"ML Molendijk","year":"2015","unstructured":"Molendijk ML, de Kloet ER (2015) Immobility in the forced swim test is adaptive and does not reflect depression. Psychoneuroendocrinology 62:389\u2013391. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.08.028","journal-title":"Psychoneuroendocrinology"},{"key":"5950_CR66","doi-asserted-by":"publisher","unstructured":"Molendijk ML, de Kloet ER (2021) Forced swim stressor: trends in usage and mechanistic consideration. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.15139","DOI":"10.1111\/ejn.15139"},{"key":"5950_CR67","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ejphar.2013.07.046","volume":"718","author":"T Mori","year":"2013","unstructured":"Mori T, Shibasaki M, Ogawa Y, Hokazono M, Wang TC, Rahmadi M et al (2013) Comparison of the behavioral effects of bupropion and psychostimulants. Eur J Pharmacol 718:370\u2013375. https:\/\/doi.org\/10.1016\/j.ejphar.2013.07.046","journal-title":"Eur J Pharmacol"},{"key":"5950_CR68","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0031-9384(97)00266-7","volume":"62","author":"DT Mueller","year":"1997","unstructured":"Mueller DT, Loft A, Eikelboom R (1997) Alternate-day wheel access: effects on feeding, body weight, and running. Physiol Behav 62:905\u2013908. https:\/\/doi.org\/10.1016\/S0031-9384(97)00266-7","journal-title":"Physiol Behav"},{"key":"5950_CR69","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","volume":"33","author":"EJ Nunes","year":"2013","unstructured":"Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y et al (2013) Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci 33:19120\u201319130. https:\/\/doi.org\/10.1523\/JNEUROSCI.2730-13.2013","journal-title":"J Neurosci"},{"key":"5950_CR70","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0269881106069938","volume":"21","author":"D Nutt","year":"2007","unstructured":"Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL et al (2007) The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol 21:461\u2013471. https:\/\/doi.org\/10.1177\/0269881106069938","journal-title":"J Psychopharmacol"},{"key":"5950_CR71","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1586\/14737175.7.10.1251","volume":"7","author":"CU Pae","year":"2007","unstructured":"Pae CU, Lim HK, Han C, Patkar AA, Steffens DC, Masand PS et al (2007) Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Rev Neurother 7:1251\u20131263. https:\/\/doi.org\/10.1586\/14737175.7.10.1251","journal-title":"Expert Rev Neurother"},{"key":"5950_CR72","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.euroneuro.2005.12.002","volume":"16","author":"GI Papakostas","year":"2006","unstructured":"Papakostas GI (2006) Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 16:391\u2013402. https:\/\/doi.org\/10.1016\/j.euroneuro.2005.12.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"5950_CR73","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","volume":"60","author":"GI Papakostas","year":"2006","unstructured":"Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M (2006) Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 60:1350\u20131355. https:\/\/doi.org\/10.1016\/j.biopsych.2006.06.015","journal-title":"Biol Psychiatry"},{"key":"5950_CR74","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00213-015-3872-7","volume":"232","author":"M Pardo","year":"2015","unstructured":"Pardo M, L\u00f3pez-Cruz L, Miguel NS, Salamone JD, Correa M (2015) Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists. Psychopharmacology 232:2377\u20132391. https:\/\/doi.org\/10.1007\/s00213-015-3872-7","journal-title":"Psychopharmacology"},{"key":"5950_CR75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/01.jcp.0000246212.03530.fd","volume":"26","author":"AA Patkar","year":"2006","unstructured":"Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P et al (2006) A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol 26:653\u2013656. https:\/\/doi.org\/10.1097\/01.jcp.0000246212.03530.fd","journal-title":"J Clin Psychopharmacol"},{"key":"5950_CR76","unstructured":"Paxinos G, Franklin KBJ (2004) The mouse brain in stereotaxic coordinates. Academic Press"},{"key":"5950_CR77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","volume":"102","author":"DJ Pettibone","year":"1984","unstructured":"Pettibone DJ, Totaro JA, Pflueger AB (1984) Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants. Eur J Pharmacol 102:425\u2013430. https:\/\/doi.org\/10.1016\/0014-2999(84)90562-4","journal-title":"Eur J Pharmacol"},{"key":"5950_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-clinpsy-050212-185606","volume":"10","author":"DA Pizzagalli","year":"2014","unstructured":"Pizzagalli DA (2014) Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol 10:393\u2013423. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050212-185606","journal-title":"Annu Rev Clin Psychol"},{"key":"5950_CR79","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/596982\/. Accessed July 18, 2020"},{"key":"5950_CR80","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1901\/jeab.1963.6-209","volume":"6","author":"D Premack","year":"1963","unstructured":"Premack D, Premack AJ (1963) Increased eating in rats deprived of running. J Exp Anal Behav 6:209\u2013212. https:\/\/doi.org\/10.1901\/jeab.1963.6-209","journal-title":"J Exp Anal Behav"},{"key":"5950_CR81","doi-asserted-by":"publisher","unstructured":"Presby RE, Rotolo RA, Yang JH, Correa M, Salamone JD (2020) Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: exploration of a binge-like eating model. Pharmacol Biochem Behav 189. https:\/\/doi.org\/10.1016\/j.pbb.2020.172851","DOI":"10.1016\/j.pbb.2020.172851"},{"key":"5950_CR82","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1600-0447.1991.tb03193.x","volume":"84","author":"L Rampello","year":"1991","unstructured":"Rampello L, Nicoletti G, Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 84:552\u2013554. https:\/\/doi.org\/10.1111\/j.1600-0447.1991.tb03193.x","journal-title":"Acta Psychiatr Scand"},{"key":"5950_CR83","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000119183","volume":"31","author":"L Rampello","year":"1995","unstructured":"Rampello L, Nicoletti G, Raffaele R, Drago F (1995) Comparative effects of amitriptyline and amineptine in patients affected by anxious depression. Neuropsychobiology 31:130\u2013134. https:\/\/doi.org\/10.1159\/000119183","journal-title":"Neuropsychobiology"},{"key":"5950_CR84","doi-asserted-by":"publisher","unstructured":"Randall PA, Pardo M, Nunes EJ, L\u00f3pez Cruz L, Vemuri VK, Makriyannis A et al (2012) Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS ONE 7. https:\/\/doi.org\/10.1371\/journal.pone.0047934","DOI":"10.1371\/journal.pone.0047934"},{"key":"5950_CR85","doi-asserted-by":"publisher","unstructured":"Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B et al (2014) The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: reversal with antidepressant drugs. PLoS ONE 9. https:\/\/doi.org\/10.1371\/journal.pone.0099320","DOI":"10.1371\/journal.pone.0099320"},{"key":"5950_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu017","volume":"18","author":"PA Randall","year":"2015","unstructured":"Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M et al (2015) Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol 18:1\u201311. https:\/\/doi.org\/10.1093\/ijnp\/pyu017","journal-title":"Int J Neuropsychopharmacol"},{"key":"5950_CR87","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00213-004-1965-9","volume":"177","author":"R Redolat","year":"2005","unstructured":"Redolat R, G\u00f3mez MC, Vicens P, Carrasco MC (2005a) Bupropion effects on aggressiveness and anxiety in OF1 male mice. Psychopharmacology 177:418\u2013427. https:\/\/doi.org\/10.1007\/s00213-004-1965-9","journal-title":"Psychopharmacology"},{"key":"5950_CR88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00008877-200502000-00007","volume":"16","author":"R Redolat","year":"2005","unstructured":"Redolat R, Vidal J, G\u00f3mez MC, Carrasco MC (2005b) Effects of acute bupropion administration on locomotor activity in adolescent and adult mice. Behav Pharmacol 16:59\u201362. https:\/\/doi.org\/10.1097\/00008877-200502000-00007","journal-title":"Behav Pharmacol"},{"key":"5950_CR89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s002130050555","volume":"136","author":"JP R\u00e9n\u00e9ric","year":"1998","unstructured":"R\u00e9n\u00e9ric JP, Lucki I (1998) Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology 136:190\u2013197. https:\/\/doi.org\/10.1007\/s002130050555","journal-title":"Psychopharmacology"},{"key":"5950_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2013.08.008","volume":"55","author":"AJ Rothschild","year":"2014","unstructured":"Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M (2014) The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. Compr Psychiatry 55:1\u201310. https:\/\/doi.org\/10.1016\/j.comppsych.2013.08.008","journal-title":"Compr Psychiatry"},{"key":"5950_CR91","doi-asserted-by":"publisher","unstructured":"Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A et al (2019) The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding. Front Pharmacol 10. https:\/\/doi.org\/10.3389\/fphar.2019.00682","DOI":"10.3389\/fphar.2019.00682"},{"key":"5950_CR92","doi-asserted-by":"publisher","unstructured":"Rotolo RA, Kalaba P, Dragacevic V, Presby RE, Neri J, Robertson E et al (2020) Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-020-05625-6","DOI":"10.1007\/s00213-020-05625-6"},{"key":"5950_CR93","doi-asserted-by":"publisher","unstructured":"Rotolo RA, Presby RE, Tracy O, Asar S, Yang JH, Correa M et al (2021) The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology. Neuropharmacology 183. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108325","DOI":"10.1016\/j.neuropharm.2020.108325"},{"key":"5950_CR94","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0166-4328(94)90153-8","volume":"61","author":"JD Salamone","year":"1994","unstructured":"Salamone JD (1994) The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 61:117\u2013133. https:\/\/doi.org\/10.1016\/0166-4328(94)90153-8","journal-title":"Behav Brain Res"},{"key":"5950_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","volume":"137","author":"JD Salamone","year":"2002","unstructured":"Salamone JD, Correa M (2002) Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137:3\u201325. https:\/\/doi.org\/10.1016\/S0166-4328(02)00282-6","journal-title":"Behav Brain Res"},{"key":"5950_CR96","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76:470\u2013485. https:\/\/doi.org\/10.1016\/j.neuron.2012.10.021","journal-title":"Neuron"},{"key":"5950_CR97","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","volume":"191","author":"JD Salamone","year":"2007","unstructured":"Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461\u2013482. https:\/\/doi.org\/10.1007\/s00213-006-0668-9","journal-title":"Psychopharmacology"},{"key":"5950_CR98","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beproc.2016.02.008","volume":"127","author":"JD Salamone","year":"2015","unstructured":"Salamone JD, Correa M, Yohn S, Lopez Cruz L, San Miguel N, Alatorre L (2015) The pharmacology of effort-related choice behavior: dopamine, depression, and individual differences. Behav Process 127:3\u201317. https:\/\/doi.org\/10.1016\/j.beproc.2016.02.008","journal-title":"Behav Process"},{"key":"5950_CR99","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/brain\/aww050","volume":"139","author":"JD Salamone","year":"2016","unstructured":"Salamone JD, Yohn SE, L\u00f3pez-Cruz L, San Miguel N, Correa M (2016) Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain 139:1325\u20131347. https:\/\/doi.org\/10.1093\/brain\/aww050","journal-title":"Brain"},{"key":"5950_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2018.00052","volume":"12","author":"JD Salamone","year":"2018","unstructured":"Salamone JD, Correa M, Yang J-H, Rotolo R, Presby R (2018) Dopamine, effort-based choice, and behavioral economics: basic and translational research. Front Behav Neurosci 12:1\u201313. https:\/\/doi.org\/10.3389\/fnbeh.2018.00052","journal-title":"Front Behav Neurosci"},{"key":"5950_CR101","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-2001-15184","volume":"34","author":"K Schmidt","year":"2001","unstructured":"Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A (2001) Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 34:66\u201372. https:\/\/doi.org\/10.1055\/s-2001-15184","journal-title":"Pharmacopsychiatry"},{"key":"5950_CR102","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/npp.2012.69","volume":"37","author":"N Shafiei","year":"2012","unstructured":"Shafiei N, Gray M, Viau V, Floresco SB (2012) Acute stress induces selective alterations in cost\/benefit decision-making. Neuropsychopharmacology 37:2194\u2013209. https:\/\/doi.org\/10.1038\/npp.2012.69","journal-title":"Neuropsychopharmacology"},{"key":"5950_CR103","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1017\/S1461145714000996","volume":"17","author":"S Sommer","year":"2014","unstructured":"Sommer S, Danysz W, Russ H, Valastro B, Flik G, Hauber W (2014) The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats. Int J Neuropsychopharmacol 17:2045\u20132056. https:\/\/doi.org\/10.1017\/S1461145714000996","journal-title":"Int J Neuropsychopharmacol"},{"key":"5950_CR104","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S1092852913000345","volume":"18","author":"DP Soskin","year":"2013","unstructured":"Soskin DP, Holt DJ, Sacco GR, Fava M (2013) Incentive salience: novel treatment strategies for major depression. CNS Spectr 18:307\u2013314. https:\/\/doi.org\/10.1017\/S1092852913000345","journal-title":"CNS Spectr"},{"key":"5950_CR105","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4088\/JCP.v63n0102","volume":"63","author":"SM Stahl","year":"2002","unstructured":"Stahl SM (2002) The psychopharmacology of energy and fatigue. J Clin Psychiatry 63:7\u20138. https:\/\/doi.org\/10.4088\/JCP.v63n0102","journal-title":"J Clin Psychiatry"},{"key":"5950_CR106","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/pcc.v06n0403","volume":"06","author":"SM Stahl","year":"2004","unstructured":"Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S (2004) A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 06:159\u2013166. https:\/\/doi.org\/10.4088\/pcc.v06n0403","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"5950_CR107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.31887\/DCNS.1999.1.3\/gstotz","volume":"1","author":"G Stotz","year":"1999","unstructured":"Stotz G, Woggon B, Angst J (1999) Psychostimulants in the therapy of treatment-resistant depression. Dialogues Clin Neurosci 1:165\u2013174. https:\/\/doi.org\/10.31887\/DCNS.1999.1.3\/gstotz","journal-title":"Dialogues Clin Neurosci"},{"key":"5950_CR108","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1073\/pnas.97.4.1856","volume":"97","author":"P Svenningsson","year":"2000","unstructured":"Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB et al (2000) Regulation of the phosphorylation of the dopamine-and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A 97:1856\u20131860. https:\/\/doi.org\/10.1073\/pnas.97.4.1856","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5950_CR109","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1073\/pnas.052712799","volume":"99","author":"P Svenningsson","year":"2002","unstructured":"Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P (2002) Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Natl Acad Sci 99:3182\u20133187. https:\/\/doi.org\/10.1073\/pnas.052712799","journal-title":"Proc Natl Acad Sci"},{"key":"5950_CR110","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/0278-5846(95)00124-E","volume":"19","author":"AJ Tanra","year":"1995","unstructured":"Tanra AJ, Kagaya A, Okamoto Y, Oka MM, Motohashi N, Yamawaki S (1995) TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced supression of spontaneous locomotor activity in rats. Prog Neuropsychopharmacol Biol Psychiatry 19:963\u2013971. https:\/\/doi.org\/10.1016\/0278-5846(95)00124-E","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5950_CR111","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","volume":"35","author":"MT Treadway","year":"2011","unstructured":"Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35:537\u2013555. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.06.006","journal-title":"Neurosci Biobehav Rev"},{"key":"5950_CR112","doi-asserted-by":"publisher","unstructured":"Treadway MT, Pizzagalli DA (2014) Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis. Biol Mood Anxiety Disord 4. https:\/\/doi.org\/10.1186\/2045-5380-4-5","DOI":"10.1186\/2045-5380-4-5"},{"key":"5950_CR113","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1037\/a0028813","volume":"121","author":"MT Treadway","year":"2012","unstructured":"Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012) Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121:553\u2013558. https:\/\/doi.org\/10.1037\/a0028813","journal-title":"J Abnorm Psychol"},{"key":"5950_CR114","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1523\/JNEUROSCI.0454-15.2015","volume":"35","author":"C Varazzani","year":"2015","unstructured":"Varazzani C, San-Galli A, Gilardeau S, Bouret S (2015) Noradrenaline and dopamine neurons in the reward\/effort trade-off: a direct electrophysiological comparison in behaving monkeys. J Neurosci 35:7866\u20137877. https:\/\/doi.org\/10.1523\/JNEUROSCI.0454-15.2015","journal-title":"J Neurosci"},{"key":"5950_CR115","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377\u2013382. https:\/\/doi.org\/10.1176\/appi.ajp.158.3.377","journal-title":"Am J Psychiatry"},{"key":"5950_CR116","doi-asserted-by":"publisher","unstructured":"Wang H, Chen X, Li Y, Tang TS, Bezprozvanny I (2010) Tetrabenazine is neuroprotective in Huntington\u2019s disease mice. Mol Neurodegener 5. https:\/\/doi.org\/10.1186\/1750-1326-5-18","DOI":"10.1186\/1750-1326-5-18"},{"key":"5950_CR117","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4088\/JCP.v61n0309","volume":"61","author":"KL Weihs","year":"2000","unstructured":"Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RMJ, Ascher JA (2000) Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry 61:196\u2013202. https:\/\/doi.org\/10.4088\/JCP.v61n0309","journal-title":"J Clin Psychiatry"},{"key":"5950_CR118","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","volume":"504","author":"J Yamada","year":"2004","unstructured":"Yamada J, Sugimoto Y, Yamada S (2004) Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 504:207\u2013211. https:\/\/doi.org\/10.1016\/j.ejphar.2004.09.057","journal-title":"Eur J Pharmacol"},{"key":"5950_CR119","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00213-019-05343-8","volume":"237","author":"JH Yang","year":"2020","unstructured":"Yang JH, Presby RE, Jarvie AA, Rotolo RA, Fitch RH, Correa M et al (2020a) Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction. Psychopharmacology 237:33\u201343. https:\/\/doi.org\/10.1007\/s00213-019-05343-8","journal-title":"Psychopharmacology"},{"key":"5950_CR120","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00213-020-05578-w","volume":"237","author":"JH Yang","year":"2020","unstructured":"Yang JH, Presby RE, Rotolo RA, Quiles T, Okifo K, Zorda E et al (2020b) The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures. Psychopharmacology 237:2845\u20132854. https:\/\/doi.org\/10.1007\/s00213-020-05578-w","journal-title":"Psychopharmacology"},{"key":"5950_CR121","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pbb.2015.05.003","volume":"135","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M et al (2015a) The role of dopamine D1 receptor transmission in effort-related choice behavior: effects of D1 agonists. Pharmacol Biochem Behav 135:217\u2013226. https:\/\/doi.org\/10.1016\/j.pbb.2015.05.003","journal-title":"Pharmacol Biochem Behav"},{"key":"5950_CR122","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","volume":"232","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Thompson C, Randall PA, Lee CA, M\u00fcller CE, Baqi Y et al (2015b) The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232:1313\u20131323. https:\/\/doi.org\/10.1007\/s00213-014-3766-0","journal-title":"Psychopharmacology"},{"key":"5950_CR123","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1007\/s00213-016-4392-9","volume":"233","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Arif Y, Haley A, Tripodi G, Baqi Y, M\u00fcller CE et al (2016a) Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization. Psychopharmacology 233:3575\u20133586. https:\/\/doi.org\/10.1007\/s00213-016-4392-9","journal-title":"Psychopharmacology"},{"key":"5950_CR124","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/npp.2015.188","volume":"41","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Collins SL, Contreras-Mora HM, Errante EL, Rowland MA, Correa M et al (2016b) Not all antidepressants are created equal: differential effects of monoamine uptake inhibitors on effort-related choice behavior. Neuropsychopharmacology 41:686\u2013694. https:\/\/doi.org\/10.1038\/npp.2015.188","journal-title":"Neuropsychopharmacology"},{"key":"5950_CR125","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuropharm.2016.06.018","volume":"109","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Errante EE, Rosenbloom-Snow A, Somerville M, Rowland M, Tokarski K et al (2016c) Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: implications for treatment of effort-related motivational symptoms in psychopathology. Neuropharmacology 109:270\u2013280. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.018","journal-title":"Neuropharmacology"},{"key":"5950_CR126","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pbb.2016.06.004","volume":"148","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Gogoj A, Haque A, Lopez-Cruz L, Haley A, Huxley P et al (2016d) Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040. Pharmacol Biochem Behav 148:84\u201391. https:\/\/doi.org\/10.1016\/j.pbb.2016.06.004","journal-title":"Pharmacol Biochem Behav"},{"key":"5950_CR127","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00213-015-4176-7","volume":"233","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Lopez-Cruz L, Hutson PH, Correa M, Salamone JD (2016e) Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology 233:949\u2013960. https:\/\/doi.org\/10.1007\/s00213-015-4176-7","journal-title":"Psychopharmacology"},{"key":"5950_CR128","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2017.09.002","volume":"161","author":"E Yuen","year":"2017","unstructured":"Yuen E, Swanson S, Witkin JM (2017) Prediction of human efficacious antidepressant doses using the mouse forced swim test. Pharmacol Biochem Behav 161:22\u201329. https:\/\/doi.org\/10.1016\/j.pbb.2017.09.002","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05950-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T04:27:21Z","timestamp":1644640041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05950-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":128,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5950"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05950-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}